{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T01:12:16Z","timestamp":1654564336920},"reference-count":0,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Compared with a physician's choice of either methotrexate or bexarotene, the CD30-directed antibody\u2013drug conjugate brentuximab vedotin led to significantly superior clinical responses in patients with cutaneous T-cell lymphomas, according to the results of the international phase III ALCANZA trial.<\/jats:p>","DOI":"10.1158\/2159-8290.cd-nb2017-012","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T01:50:41Z","timestamp":1485309041000},"page":"OF3-OF3","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Brentuximab Beats Standard Therapies for CTCL"],"prefix":"10.1158","volume":"7","member":"1086","published-online":{"date-parts":[[2017,3,5]]},"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/7\/3\/OF3\/5780\/Brentuximab-Beats-Standard-Therapies-for","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/7\/3\/OF3\/5780\/Brentuximab-Beats-Standard-Therapies-for","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:42:10Z","timestamp":1654562530000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/7\/3\/OF3\/5780\/Brentuximab-Beats-Standard-Therapies-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,5]]},"published-print":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-nb2017-012","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]}}}